AI Insight
This review examines how molecular and cellular-level brain perturbations can be mathematically reduced to whole-brain models while preserving mechanistic interpretability. The authors focus on receptor-aware adaptive mean-field models that maintain explicit links to synaptic receptors, conductances, and spike adaptation across scales, comparing this approach to other reduction strategies including phenomenological models, spiking networks, and machine learning surrogates. They identify key assumptions required for validity (population homogeneity, Markovian dynamics, moment closure) and argue that cross-scale models should be evaluated based on which interventions and observables they preserve, their identifiability limits, and computational costs rather than universal applicability.
Why it matters
Understanding how drugs and diseases affect brain activity requires bridging molecular mechanisms to observable brain signals. This framework helps researchers choose appropriate modeling strategies for specific questions, potentially improving predictions of how pharmaceutical interventions or pathological changes at the receptor level manifest in measurable brain dynamics like EEG or fMRI.
Understand the Science
⚠️ Preprint – Noch nicht peer-reviewed
Dieser Artikel wurde noch nicht von unabhängigen Experten begutachtet. Die Ergebnisse sind vorläufig und sollten mit Vorsicht interpretiert werden.
Abstract: Many pharmacological and pathological perturbations arise at molecular, synaptic, or cellular scales, but are observed through population and whole-brain signals. Cross-scale reductions must preserve relevant mechanisms while remaining tractable. This review asks which microscopic mechanisms remain explicit, interpretable, and testable after reduction, and what claims these models support. Using receptor-aware adaptive mean fields from the master-equation lineage as a worked case, we trace finite-size population statistics and semi-analytical transfer functions into conductance-based adaptive nodes coupled through the connectome. We compare this strategy with phenomenological neural masses, low-dimensional and population-density reductions, large-scale spiking models, and learned or hybrid surrogates, including computational work and memory traffic. Receptor-dependent synaptic kinetics, conductance state, and spike-frequency adaptation can remain manipulable across scales, enabling interpretable interventions and testable mesoscopic and macroscopic consequences. However, this relies on coarse-grained Markovianity, population homogeneity, quasi-stationary transfer functions, moment closure, regional uniformity, and measurement-specific observation models. First-order implementations discard covariance dynamics, while macroscopic agreement cannot identify a unique molecular cause. Node-local biological detail mainly changes prefactors, whereas dense global covariances change the scaling class. Cross-scale models should therefore be judged by the interventions and observables they preserve, validity domain, identifiability, empirical adequacy, and computational burden. Receptor-aware mean fields are not universal, but offer a transparent, tractable strategy for selected mechanistic questions when each reduction step is independently validated.